Doctors in the US and Europe are prescribing antibiotics after the introduction of superbugs resistant to several antibiotics, according to a report published in the New England Journal of Medicine.
The US Centers for Disease Control and Prevention (CDC) says more than 10 million prescriptions have been filled since the end of last year, with the average person taking a dose of an antibiotic for more than a year.
However, there are a number of new antibiotics being used in Europe and the US, according the CDC.
A study published in The Lancet medical journal on Friday found that patients with severe symptoms such as diarrhea, fevers and pneumonia were increasingly taking the new antibiotics, which are commonly used in the treatment of respiratory infections.
In France, which has seen the emergence of antibiotic resistance, more than half of patients with a severe case of pneumonia and fevers had taken at least one antibiotic.
In the US the report says that in 2014 there were more than 12,000 antibiotic prescriptions in France, but in 2015 there were just 1,100.
The CDC also said there are more than 300,000 prescriptions for antibiotics prescribed in the UK.
The report, from researchers at Johns Hopkins University, examined more than 2.5 million prescriptions in the United States from 2013 to 2017.
They found that antibiotic prescriptions for severe pneumonia increased from 7,890 to 10,800, for severe fevers from 3,300 to 4,400, for pneumonia from 1,000 to 1,200 and for pneumonia related to antibiotic-resistance from 2,300.
Dr David Deutsch, a researcher at the CDC, told The Lancet that while the rise in antibiotic prescriptions was “striking” there was no evidence that it was due to antibiotic resistance.
“The trend is not due to a new superbug that we just have not found,” he said.
Dr Deutsch said he believed the rise could be down to an increase in the use of antibiotics in hospitals and in the intensive care unit.
He said the US was facing a major challenge to tackling antibiotic-related infections such as pneumonia and other bacterial infections.
He warned that the US could face a similar challenge to Europe in tackling antibiotic resistance if antibiotics were used less often and for shorter periods of time.
“We will see an increase of antibiotic prescriptions from the current level of 4,800 per year,” Dr Deitsch said.
In an interview with the US TV network ABC News, Dr Debs said it was a challenge for the CDC to find the right balance between prescribing antibiotics for patients who have severe symptoms and people who have no symptoms.
“There’s going to be an increasing number of people who are using antibiotics in their practice that aren’t really in their patient care,” Dr debs said.
“If we don’t have the right kind of data, we won’t be able to determine what’s going on and that’s going in the direction of increased prescribing.” “
Dr DeSchultz said the CDC needed to make sure it was not “over prescribing” antibiotics. “
If we don’t have the right kind of data, we won’t be able to determine what’s going on and that’s going in the direction of increased prescribing.”
Dr DeSchultz said the CDC needed to make sure it was not “over prescribing” antibiotics.
He added that “we have a lot of good antibiotics that are being prescribed by physicians and hospitals, and we’re doing a very good job with the antibiotics that we have.”